recarbrio
merck sharp & dohme b.v. - monohidrat Имипенем, циластатин natrija, relebactam monohidrat - Грамотрицательные bakterijske infekcije - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 i 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 i 5. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.
recarbrio 500 mg/1 bočica+ 500 mg/1 bočica+ 250 mg/1 bočica prašak za rastvor za infuziju
merck sharp & dohme bh d.o.o. - cilastatin, imipenem, relebaktam - prašak za rastvor za infuziju - 500 mg/1 bočica+ 500 mg/1 bočica+ 250 mg/1 bočica - 1 bočica praška za rastvor za infuziju sadrži 500 mg imipenema u obliku imipenem hidrata, 500 mg cilastatina u obliku cilastatin natrija i 250 mg relebaktama u obliku relebaktam hidrata